MediSieve shortlisted for 2019 Emerging Technologies Competition

MediSieve shortlisted for 2019 Emerging Technologies Competition, run by the Royal Society of Chemistry
Created on 20-09-2019

MediSieve was shortlisted for the final round of 2019 Emerging Technology Competition, run by the Royal Society of Chemistry.

The Emerging Technology Competition is held every year and is targeted at early stage companies and academic entrepreneurs who want to commercialise their technologies to make a global impact. This prestigous competition is backed by multinational corporations and one of the world top business school: Cambridge Judge Business School.

The participants are competing within several categories:

• Health
• Energy & environment
• Food & drink
• Enabling technologies

This year MediSieve was announced as a finalist in the health category. We are going to showcase our technology to a panel of judges and live audience during the final on 28 October 2019 at Chemistry Means Business event.

Read more and register for the final: https://www.rsc.org/competitions/emerging-technologies/shortlisted-entries-2019/#health

Sort by:

Latest News

MediSieve expands its research into treating COVID-19
April 29, 2020

Recent studies show that patients with the most serious forms of the coronavirus had high levels of something called IL-6, a common inflammatory cytokine, which MediSieve has previously encountered while researching sepsis and cytokine storms.

COVID-19 Response
April 03, 2020

Recent clinical data has shown that >50 per cent of hospitalised COVID-19 patients develop cytokine storm syndromes, and that these are a major driver of mortality.